Matão Controlling Hypertension (MatCH Study): Rationale and Design

NCT03147092 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

15000

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Blood Pressure

Interventions

DRUG: Captopril 25Mg, Hydrochlorothiazide 25Mg Oral Tablet,
DRUG: Atenolol
DRUG: Losartan potassium 50mg
DRUG: Clonidine

Sponsor

Centro Neurológico de Pesquisa e Reabiitação, Brazil